<DOC>
	<DOCNO>NCT00568945</DOCNO>
	<brief_summary>This trial primary goal show BAY68-4986 low ventricular rate patient indication persistent atrial fibrillation .</brief_summary>
	<brief_title>Study Investigate Effect A1 Agonist Capadenoson Ventricular HR Patients With Persistent Permanent Atrial Fibrillation .</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Male and/or female ( without childbearing potential ) white patient History persistent permanent atrial fibrillation 18 75 year age Patients highrisk cardiovascular disease Stroke myocardial infarction Relevant pathological change ECG echocardiography Medication affect ventricular response Afib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Capadenoson</keyword>
</DOC>